Tanaka Yuko, Matsuda Yoshikazu, Tsumoto Tomoyuki, Terada Tomoaki
Department of Stroke Medicine and Endovascular Therapy, University of Occupational and Environmental Health, Kitakyushu City, Japan.
Department of Neurological Surgery, Showa Medical University, Fujigaoka Hospital, Yokohama, Japan.
Surg Neurol Int. 2025 Jun 20;16:250. doi: 10.25259/SNI_306_2025. eCollection 2025.
Visual field defect and visual impairment are important but poorly characterized complications after flow-diverter (FD) stent placement for internal carotid artery (ICA) aneurysms.
We retrospectively analyzed 31 consecutive patients with 32 ICA aneurysms treated by FD stent implantation between October 2015 and April 2021. Aneurysms were classified into two groups those with visual symptoms before and after FD stenting (symptomatic group) and those without (asymptomatic group). We analyzed patients' background characteristics, treatment details, and imaging findings.
Visual symptoms were present in 25% (8/32) of aneurysms and worsened after treatment in 9.4% (3/32). Aneurysm enlargement was more common in the symptomatic group than the asymptomatic group (50% vs. 4.1%; odds ratio 23.0, 95% confidence interval [CI] 2.0-262.6, = 0.0086). Poor visualization of the ophthalmic artery after procedure was observed in 50% versus 12.5% (odds ratio 7.0, 95% confidence interval 1.1-44.1, = 0.047). No central retinal artery occlusion or cerebral ischemic events were observed. All three deteriorating cases improved after high dose steroids: one required additional FD stenting.
In this single-center retrospective cohort, visual symptoms after FD stenting were relatively common but were usually reversible. Aneurysm enlargement and early loss of ophthalmic-artery flow identify patients at higher visual risk. Early steroid therapy and, when necessary, further endovascular treatment may mitigate visual deterioration.
视野缺损和视力损害是颈内动脉(ICA)动脉瘤采用血流导向(FD)支架置入术后的重要并发症,但目前对其特征的描述尚不充分。
我们回顾性分析了2015年10月至2021年4月期间连续31例接受FD支架植入治疗的32个ICA动脉瘤患者。将动脉瘤分为两组,即FD支架置入前后有视觉症状的患者(有症状组)和无视觉症状的患者(无症状组)。我们分析了患者的背景特征、治疗细节和影像学表现。
25%(8/32)的动脉瘤存在视觉症状,9.4%(3/32)的患者在治疗后症状加重。有症状组的动脉瘤增大比无症状组更常见(50%对4.1%;优势比23.0,95%置信区间[CI]2.0 - 262.6,P = 0.0086)。术后眼动脉显影不佳在有症状组为50%,而无症状组为12.5%(优势比7.0,95%置信区间1.1 - 44.1,P = 0.047)。未观察到视网膜中央动脉阻塞或脑缺血事件。所有3例症状恶化的患者在接受大剂量类固醇治疗后均有改善:1例需要额外进行FD支架置入。
在这个单中心回顾性队列研究中,FD支架置入术后的视觉症状相对常见,但通常是可逆的。动脉瘤增大和眼动脉血流早期丧失可识别出视觉风险较高的患者。早期类固醇治疗以及必要时的进一步血管内治疗可能减轻视力恶化。